These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21173933)

  • 21. Indications for Invasive Prenatal Testing before and after Noninvasive Prenatal Screening.
    Gill LA; Prosen TL
    Am J Perinatol; 2017 Sep; 34(11):1084-1087. PubMed ID: 28614867
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
    Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antenatal noninvasive DNA testing: clinical experience and impact.
    Ferres MA; Hui L; Bianchi DW
    Am J Perinatol; 2014 Aug; 31(7):577-82. PubMed ID: 24683075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid aneuploidy testing versus traditional karyotyping: is it better to know more?
    Leung TN
    Hong Kong Med J; 2008 Feb; 14(1):4-5. PubMed ID: 18239236
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of a novel prenatal diagnosis model with combination of karyotyping and BACs-on-Beads
    Mou K; Liu Y; Wei X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):332-335. PubMed ID: 28604949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chip-Based Digital PCR Approach Provides A Sensitive and Cost-Effective Single-Day Screening Tool for Common Fetal Aneuploidies-A Proof of Concept Study.
    Nykel A; Kaszkowiak M; Fendler W; Gach A
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory.
    Dheedene A; Sante T; De Smet M; Vanbellinghen JF; Grisart B; Vergult S; Janssens S; Menten B
    Prenat Diagn; 2016 Aug; 36(8):699-707. PubMed ID: 27176606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: a prospective cohort study.
    Wang Y; Cao L; Liang D; Meng L; Wu Y; Qiao F; Ji X; Luo C; Zhang J; Xu T; Yu B; Wang L; Wang T; Pan Q; Ma D; Hu P; Xu Z
    Am J Obstet Gynecol; 2018 Feb; 218(2):244.e1-244.e17. PubMed ID: 29128521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-invasive genetic prenatal testing--an ethical discourse].
    Dudenhausen JW
    Z Geburtshilfe Neonatol; 2014 Dec; 218(6):238-41. PubMed ID: 25518827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Array CGH in routine prenatal diagnosis practice.
    Cavalli P; Cavallari U; Novelli A
    Prenat Diagn; 2012 Jul; 32(7):708-9; author reply 711-2. PubMed ID: 22752938
    [No Abstract]   [Full Text] [Related]  

  • 32. Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy.
    Fan HC; Blumenfeld YJ; El-Sayed YY; Chueh J; Quake SR
    Am J Obstet Gynecol; 2009 May; 200(5):543.e1-7. PubMed ID: 19375573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of genomic technology in prenatal diagnosis.
    Dugoff L
    N Engl J Med; 2012 Dec; 367(23):2249-51. PubMed ID: 23215562
    [No Abstract]   [Full Text] [Related]  

  • 34. Prenatal Diagnosis of 4q Terminal Deletion and Review of the Literature.
    Tidrenczel Z; Tardy EP; Pikó H; Sarkadi E; Böjtös I; Demeter J; Simon J; Kósa JP; Beke A
    Cytogenet Genome Res; 2019; 158(2):63-73. PubMed ID: 31261151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal fraction evaluation in non-invasive prenatal screening (NIPS).
    Hestand MS; Bessem M; van Rijn P; de Menezes RX; Sie D; Bakker I; Boon EMJ; Sistermans EA; Weiss MM
    Eur J Hum Genet; 2019 Feb; 27(2):198-202. PubMed ID: 30254213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should array CGH be applied to all routine prenatal care?
    Lin TH; Lin SY; Lee CN; Shih JC; Chung CH; Su YN
    Prenat Diagn; 2012 Jul; 32(7):710; author reply 711-2. PubMed ID: 22752939
    [No Abstract]   [Full Text] [Related]  

  • 37. [Noninvasive prenatal diagnosis of trisomy 21, 18 and 13 using cell-free fetal DNA].
    Gorzelnik K; Bijok J; Zimowski JG; Jakiel G; Roszkowski T
    Ginekol Pol; 2013 Aug; 84(8):714-9. PubMed ID: 24191506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare structural chromosomal abnormalities in prenatal diagnosis; clinical and cytogenetic findings on 10125 prenatal cases.
    Yakut S; Çetin Z; Şİmşek M; Mendilcioğlu II; Toru HS; Berker Karaüzüm S; Lüleci G
    Turk Patoloji Derg; 2015; 31(1):36-44. PubMed ID: 25301051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of national guidance for anomaly screening and invasive testing: unintended consequences.
    Alberry M; Hassan WA; Goodburn S; Brockelsby J; Wladimiroff J; Nash R; Lees C
    Arch Dis Child Fetal Neonatal Ed; 2014 Jan; 99(1):F83-6. PubMed ID: 23833074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of ultrasonic and cytogenetic markers in prenatal diagnostics].
    Sopko NI; Tavokina LV; Buĭnova VA; Bychkova AM
    Tsitol Genet; 2006; 40(6):33-9. PubMed ID: 17243374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.